{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:48:09Z","timestamp":1790102889003,"version":"4.0.1"},"reference-count":117,"publisher":"Wiley","issue":"S5","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000085","name":"Ontario HIV Treatment Network","doi-asserted-by":"publisher","award":["EFP\u20101113"],"award-info":[{"award-number":["EFP\u20101113"]}],"id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Int AIDS Soc."],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite advances in HIV and hepatitis C virus (HCV) treatment, people who use drugs (PWUD) face significant barriers along prevention and treatment cascades. Safer supply programmes (SSPs) providing prescribed pharmaceutical alternatives to the unregulated drug supply may create opportunities for enhanced healthcare engagement and person\u2010centred care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a qualitative study examining four SSPs in Ontario, Canada between February and October 2021. Semi\u2010structured interviews were conducted with 52 patients and 21 providers (including physicians, registered nurse practitioners, nurses and allied health professionals). Interviews explored experiences with safer supply and HIV\/HCV care. Analysis used thematic techniques guided by the Consolidated Framework for Implementation Research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SSPs supported HIV\/HCV care by first addressing patients\u2019 substance use needs, which created subsequent opportunities for building trust for broader health engagement. Providers identified the safer supply model as giving PWUD something they wanted, which then opened opportunities to discuss HIV, HCV, and other sexually transmitted and blood\u2010borne infections. SSPs provided opportunities to support patients with HIV and HCV testing and treatment initiation, and safer supply medications were bundled with HIV and HCV medications to support adherence. Non\u2010punitive approaches helped overcome previous negative healthcare experiences by prioritizing patient autonomy. Implementation challenges included balancing flexible, patient\u2010directed care with programme requirements and coordinating comprehensive services around individual needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SSPs may improve HIV\/HCV care delivery for PWUD by building services around their priorities and lived realities. The integration of safer supply with HIV\/HCV care through daily dispensing and wraparound services showed promise for engaging people previously disconnected from care. While findings suggested improved treatment outcomes, limitations included data collection during COVID\u201019, limited representation of some populations and a focus on opioid\u2010only programmes. Research examining long\u2010term outcomes and programme sustainability is needed as SSPs face growing scrutiny and closure in Canada.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jia2.70038","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:53:45Z","timestamp":1759917225000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u201cFrom an HCV and HIV point of view, it's been remarkable\u201d: A qualitative study about using prescribed safer supply to support people who use drugs along the HIV and HCV prevention and treatment cascades in Ontario, Canada"],"prefix":"10.1002","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1380-2016","authenticated-orcid":false,"given":"Adrian","family":"Guta","sequence":"first","affiliation":[{"name":"School of Social Work University of Windsor  Windsor Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Rudzinski","sequence":"additional","affiliation":[{"name":"School of Social Work University of Windsor  Windsor Ontario Canada"},{"name":"Dalla Lana School of Public Health University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilou","family":"Gagnon","sequence":"additional","affiliation":[{"name":"School of Nursing University of Victoria  Victoria British Columbia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose A.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Kolla","sequence":"additional","affiliation":[{"name":"Division of Population Health and Applied Health Sciences Faculty of Medicine Memorial University  St. John's Newfoundland and Labrador Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"German","sequence":"additional","affiliation":[{"name":"Department of Health Behavior and Society Bloomberg School of Public Health Johns Hopkins University  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kryszajtys","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Perri","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sereda","sequence":"additional","affiliation":[{"name":"London InterCommunity Health Centre  London Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sterling\u2010Murphy","sequence":"additional","affiliation":[{"name":"School of Social Work University of Windsor  Windsor Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Strike","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"e_1_2_11_2_1","volume-title":"Canada's Progress Towards Ending the HIV Epidemic, 2022","author":"Public Health Agency of Canada","year":"2024"},{"key":"e_1_2_11_3_1","volume-title":"HIV diagnoses, deaths, and prevalence: 2025 update","author":"Centers for Disease Control and Prevention","year":"2025"},{"key":"e_1_2_11_4_1","unstructured":"Public Health Agency of Canada.Canada's progress towards eliminating viral hepatitis as a public health concern.2024(accessed June 22 2025).https:\/\/www.canada.ca\/en\/public\u2010health\/services\/publications\/diseases\u2010conditions\/progress\u2010towards\u2010eliminating\u2010viral\u2010hepatitis\u2010threat\u20102021.html"},{"key":"e_1_2_11_5_1","volume-title":"Viral hepatitis national strategic plan for the United States: a roadmap to elimination (2021\u20132025)","author":"U.S. Department of Health and Human Services","year":"2020"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00178-0"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac543"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305379"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.11.014"},{"issue":"3","key":"e_1_2_11_11_1","first-page":"iii7","article-title":"The role of sexual transmission of HIV infection among injection and non\u2010injection drug users","volume":"80","author":"Strathdee SA","year":"2003","journal-title":"J Urban Health"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03457-9"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10728-020-00406-w"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.04.017"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/07067437231188202"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-025-01029-1"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102773"},{"key":"e_1_2_11_18_1","article-title":"Supervised safe consumption sites\u2014lessons and opportunities for North America","volume":"39","author":"Zhu DT","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-86"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1644-y"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1826-2"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13574"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25051"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00013-X"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.01.001"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa686"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-016-0120-0"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30327-8"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.04.013"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-023-00484-6"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckad008"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa612"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14012"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103872"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15316"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.241173"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786"},{"key":"e_1_2_11_38_1","doi-asserted-by":"crossref","unstructured":"MancherM LeshnerAI.Medications for opioid use disorder save lives.2019.","DOI":"10.17226\/25310"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108647"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.16954"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00535-y"},{"key":"e_1_2_11_42_1","volume-title":"Opioid\u2010 and stimulant\u2010related harms in Canada","author":"Substance\u2010related Overdose and Mortality Surveillance Task Group on behalf of the Council of Chief Medical Officers of Health","year":"2025"},{"key":"e_1_2_11_43_1","unstructured":"National Center for Health Statistics.U.S. overdose deaths decrease almost 27% in 2024.2025(accessed June 22 2025).https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2025\/20250514.htm"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03908-x"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae372"},{"key":"e_1_2_11_46_1","volume-title":"Methadone treatment for people who use fentanyl: recommendations","author":"Bromley L","year":"2021"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108832"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-021-00234-w"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102896"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102958"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15862"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-021-00581-w"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/23996544231203896"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.4800"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2020.81.556"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104152"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102769"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2022.83.621"},{"key":"e_1_2_11_59_1","unstructured":"HealthCanada.Safer supply.2023. Accessed August 24 2025 https:\/\/www.canada.ca\/en\/health\u2010canada\/services\/opioids\/responding\u2010canada\u2010opioid\u2010crisis\/safer\u2010supply.html."},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-025-01177-0"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104339"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00817-7"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1177\/00914509241301454"},{"key":"e_1_2_11_64_1","article-title":"Safer Opioid Supply programs: hydromorphone prescribing in Ontario as a harm reduction intervention to combat the drug poisoning crisis","author":"Schmidt RA","year":"2024","journal-title":"Can J Public Health"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13745"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2023.2238308"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-024-00598-7"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2025.100338"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(25)00070-2"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-025-01006-8"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229713"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.220892"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-020-00489-9"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103601"},{"key":"e_1_2_11_75_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076336","article-title":"Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study","volume":"384","author":"Slaunwhite A","year":"2024","journal-title":"BMJ"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103742"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20200021"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209341"},{"key":"e_1_2_11_79_1","first-page":"1","article-title":"Nurse\u2010led safer opioid supply and HIV pre\u2010exposure prophylaxis: a novel pilot project","volume":"9","author":"Haines","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00788-9"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-69909-7_3470-2"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-022-00494-y"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26125"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210096"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000073"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2016.03.001"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0347-x"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(22)00159-6"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25211"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-022-00722-x"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12758"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.11389"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000004056"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1080\/13691058.2020.1776397"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01029-3"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04436-6"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104389"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-018-2284-1"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa130"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.05.044"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109573"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14634"},{"key":"e_1_2_11_103_1","unstructured":"Centers for Disease Control.National Progress Report 2025: Reduce reported rate* of new hepatitis C virus infections among persons who inject drugs\u2020 by \u226525%. Accessed August 24 2025 https:\/\/www.cdc.gov\/hepatitis\/policy\/npr\/2021\/NationalProgressReport\u2010HepC\u2010ReduceInfectionsPWID.htm"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa574"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104600"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104423"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003199"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae599"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-7-11"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.51988"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104731"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104665"},{"key":"e_1_2_11_113_1","doi-asserted-by":"crossref","unstructured":"SandsetT.\u2018Ending AIDS\u2019 in the age of biopharmaceuticals: the individual the state and the politics of prevention.Routledge;2020.","DOI":"10.4324\/9780429197000"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2023.2170807"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104537"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104330"},{"key":"e_1_2_11_117_1","unstructured":"Statistics Canada.Canada's population clock (real\u2010time model).2024(accessed December 14 2024).https:\/\/www150.statcan.gc.ca\/n1\/pub\/71\u2010607\u2010x\/71\u2010607\u2010x2018005\u2010eng.htm"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111399"}],"container-title":["Journal of the International AIDS Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.70038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jia2.70038","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jia2.70038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:22:41Z","timestamp":1785457361000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jia2.70038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":117,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/jia2.70038"],"URL":"https:\/\/doi.org\/10.1002\/jia2.70038","archive":["Portico"],"relation":{},"ISSN":["1758-2652","1758-2652"],"issn-type":[{"value":"1758-2652","type":"print"},{"value":"1758-2652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2024-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70038"}}